| Source: |
| Type: |
| The effectiveness of chemotherapy by increasing cancer cell sensitivity to the drugs used to treat them, which is known as “chemo-sensitization”. Possible Chemo-Sensitizers: -Curcumin -Resveratrol -EGCG -Quercetin -Genistein -Berberine -Piperine: alkaloid from black pepper -Ginsenosides: active components of ginseng -Silymarin -Allicin -Lycopene -Ellagic acid -Caffeic acid phenethyl ester -flavopiridol -oleandrin -Ursolic acid -butein -Betulinic acid |
| 5819- | CBD, | The potential role of cannabidiol (CBD) in lung cancer therapy: a systematic review of preclinical and clinical evidence |
| - | Review, | Lung, | NA |
| 5974- | CDT, | Chemodynamic nanomaterials for cancer theranostics |
| - | Review, | Var, | NA |
| 5965- | CEL, | Cisplatin, | Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway |
| - | in-vitro, | OS, | MG63 |
| 5954- | CEL, | The molecular mechanisms of celecoxib in tumor development |
| - | Review, | Var, | NA |
| 5939- | Cela, | Chemo, | Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells |
| - | in-vitro, | Melanoma, | U266 | - | in-vitro, | Melanoma, | RPMI-8226 |
| 5938- | Cela, | Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application |
| - | Review, | Var, | NA |
| 5950- | Cela, | Anticancer Inhibitors of Hsp90 Function: Beyond the Usual Suspects |
| - | Review, | Var, | NA |
| 6615- | Cen, | Asiaticoside suppresses cell proliferation by inhibiting the NF-κB signaling pathway in colorectal cancer |
| - | vitro+vivo, | CRC, | HCT116 | - | in-vitro, | CRC, | SW480 | - | in-vitro, | CRC, | LoVo |
| 6017- | CGA, | Therapeutic Potential of Chlorogenic Acid in Chemoresistance and Chemoprotection in Cancer Treatment |
| - | Review, | Var, | NA |
| 6002- | CGA, | Chlorogenic Acid: A Systematic Review on the Biological Functions, Mechanistic Actions, and Therapeutic Potentials |
| - | Review, | Var, | NA | - | Review, | Diabetic, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
| 6009- | CGA, | Chlorogenic Acid: An In-Depth Review of Its Effectiveness in Cancer Treatment |
| - | Review, | Var, | NA |
| 6026- | CGA, | Chlorogenic Acid: The Conceivable Chemosensitizer Leading to Cancer Growth Suppression |
| - | Review, | Var, | NA |
| 5994- | Chit, | Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action |
| - | Review, | Var, | NA |
| 5990- | Chit, | Chitosan Nanoparticles for Targeted Cancer Therapy: A Review of Stimuli-Responsive, Passive, and Active Targeting Strategies |
| - | Review, | Var, | NA |
| 4481- | Chit, | Antioxidant Properties and Redox-Modulating Activity of Chitosan and Its Derivatives: Biomaterials with Application in Cancer Therapy |
| - | Review, | Var, | NA |
| 4490- | Chit, | FA, | Chitosan Nanoparticle-Based Drug Delivery Systems: Advances, Challenges, and Future Perspectives |
| - | Review, | Var, | NA |
| 4489- | Chit, | SeNPs, | Inhibiting Metastasis and Improving Chemosensitivity via Chitosan-Coated Selenium Nanoparticles for Brain Cancer Therapy |
| - | in-vitro, | GBM, | U87MG |
| 6070- | CHL, | Preclinical evaluation of sodium copper chlorophyllin: safety, pharmacokinetics, and therapeutic potential in breast cancer chemotherapy and cyclophosphamide-induced bladder toxicity |
| - | in-vitro, | BC, | 4T1 |
| 6073- | CHL, | GEM, | Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis |
| - | in-vitro, | PC, | NA |
| - | vitro+vivo, | BC, | 4T1 |
| 6130- | CHr, | Anticancer Properties of Chrysin on Colon Cancer Cells, In vitro and In vivo with Modulation of Caspase-3, -9, Bax and Sall4 |
| - | vitro+vivo, | Colon, | CT26 |
| 6135- | CHr, | Chrysin as a Multifunctional Therapeutic Flavonoid: Emerging Insights in Pathogenesis Management: A Narrative Review |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6136- | CHr, | Tras, | Synergistic anticancer effects of Chrysin and trastuzumab in HER2-Positive breast cancer cells |
| - | in-vitro, | BC, | SkBr3 | - | in-vitro, | BC, | BT474 | - | in-vitro, | Nor, | MCF10 |
| 6125- | CHr, | Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells |
| - | in-vitro, | SCC, | NA |
| 2591- | CHr, | doxoR, | Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway |
| - | in-vitro, | HCC, | Bel-7402 |
| 2801- | CHr, | AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells |
| - | in-vitro, | Lung, | A549 |
| 2803- | CHr, | 5-FU, | Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells |
| - | in-vitro, | GC, | AGS |
| 2806- | CHr, | Se, | Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy |
| - | in-vitro, | Var, | NA |
| 2795- | CHr, | Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53 |
| - | in-vitro, | Liver, | HepG2 |
| 2780- | CHr, | Anti-cancer Activity of Chrysin in Cancer Therapy: a Systematic Review |
| - | Review, | Var, | NA |
| 2784- | CHr, | Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review) |
| - | Review, | Var, | NA |
| 2786- | CHr, | Chemopreventive and therapeutic potential of chrysin in cancer: mechanistic perspectives |
| - | Review, | Var, | NA |
| 2788- | CHr, | Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action |
| - | Review, | Var, | NA |
| 6165- | Cin, | doxoR, | Cinnamaldehyde potentiates cytotoxic and apoptogenic effects of doxorubicin in prostate cancer cell line |
| - | in-vitro, | Pca, | PC3 |
| 6160- | Cin, | Cinnamaldehyde induces apoptosis and enhances anti-colorectal cancer activity via covalent binding to HSPD1 |
| - | vitro+vivo, | CRC, | HCT116 |
| 6141- | Cin, | The role and mechanism of cinnamaldehyde in cancer |
| - | Review, | Var, | NA |
| 6140- | Cin, | HCAs, | Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review) |
| - | Review, | Var, | NA |
| 6147- | Citrate, | The dual role of citrate in cancer |
| - | Review, | Var, | NA |
| 1593- | Citrate, | Citrate Induces Apoptotic Cell Death: A Promising Way to Treat Gastric Carcinoma? |
| - | in-vitro, | GC, | BGC-823 | - | in-vitro, | GC, | SGC-7901 |
| 1583- | Citrate, | Extracellular citrate and metabolic adaptations of cancer cells |
| - | Review, | Var, | NA |
| 1587- | Citrate, | ATP citrate lyase: A central metabolic enzyme in cancer |
| - | Review, | Var, | NA |
| 1585- | Citrate, | Sodium citrate targeting Ca2+/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer |
| - | in-vitro, | Ovarian, | SKOV3 | - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Nor, | HEK293 |
| 1584- | Citrate, | Anticancer effects of high-dose extracellular citrate treatment in pancreatic cancer cells under different glucose concentrations |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | PC, | PANC1 |
| 1578- | Citrate, | Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update |
| - | Review, | Var, | NA |
| 1576- | Citrate, | Targeting citrate as a novel therapeutic strategy in cancer treatment |
| - | Review, | Var, | NA |
| 1574- | Citrate, | Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Melanoma, | WM983B | - | in-vivo, | NA, | NA |
| 4775- | CoQ10, | Chemo, | Chemotherapy induces an increase in coenzyme Q10 levels in cancer cell lines |
| - | in-vitro, | Var, | NA |
| 4762- | CoQ10, | The role of coenzyme Q10 as a preventive and therapeutic agent for the treatment of cancers |
| - | Review, | Var, | NA |
| 4763- | CoQ10, | Chemo, | doxoR, | Effect of Coenzyme Q10 on Doxorubicin Cytotoxicity in Breast Cancer Cell Cultures |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT549 |
| 4764- | CoQ10, | VitE, | Auxiliary effect of trolox on coenzyme Q10 restricts angiogenesis and proliferation of retinoblastoma cells via the ERK/Akt pathway |
| - | in-vitro, | RPE/RB, | Y79 | - | in-vitro, | Nor, | ARPE-19 | - | in-vivo, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1106 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid